No video for q12h is available at this time.
New Clinical Data Support Broad Profile for Telaprevir in Patients ... - Phramalive.com
-- PROVE 3 data show 52% SVR12 in HCV treatment-failure patients with 24-week treatment duration -- -- PROVE 2 final results confirm 69% SVR in HCV treatment-naïve patients with 24-week treatment duration -- -- C208 study interim analysis supports ...
Tibotec Begins Enrollment in Europe for Phase III Trial of Telaprevir ... - Phramalive.com
CORK, Ireland, November 20 /PRNewswire/ -- Tibotec BVBA today announced that it has begun enrolling patients in its phase III study of telaprevir (VX-950), an investigational protease inhibitor (PI), in patients with chronic genotype 1 hepatitis C ...
Do you prefer to listen to your q12h gossip? Check out Podzy Podcast Directory > q12h.
Looking for q12h related products, then look no further. Try our new q12h Shop.